Siegal D, Su W S, DaBreo D, Puglia M, Gregor L, Gangji A S
Division of Nephrology and Transplantation, McMaster University and St. Joseph's Health Care, Hamilton, Ontario, Canada.
Division of Gastroenterology, McMaster University, Ontario Canada.
Int J Organ Transplant Med. 2011;2(3):126-32.
Primary hyperoxaluria type-1 (PH1) is a rare inherited autosomal recessive disorder in which a deficiency of the hepatic enzyme alanine-glyoxylate aminotransferase leads to endogenous oxalate overproduction, renal failure, systemic oxalate deposition and death. As hemodialysis provides insufficient oxalate clearance, patients ultimately require both liver and kidney transplantation for correction of the metabolic abnormality and oxalate excretion. Herein, we describe a young adult male with end-stage renal disease and systemic oxalosis causing progressive disabling multi-organ dysfunction while awaiting transplantation. We review the literature regarding liver-kidney transplantation and suggest that for patients with PH1, a standardized assessment of organ dysfunction and functional impairment may improve identification of patients requiring urgent transplantation thereby reducing the morbidity and mortality that can occur with delayed transplantation.
1型原发性高草酸尿症(PH1)是一种罕见的常染色体隐性遗传疾病,其中肝脏酶丙氨酸-乙醛酸转氨酶缺乏会导致内源性草酸盐产生过多、肾衰竭、全身性草酸盐沉积和死亡。由于血液透析对草酸盐的清除不足,患者最终需要进行肝肾联合移植以纠正代谢异常和草酸盐排泄。在此,我们描述了一名患有终末期肾病和全身性草酸osis的年轻成年男性,在等待移植期间导致进行性致残性多器官功能障碍。我们回顾了有关肝肾移植的文献,并建议对于PH1患者,对器官功能障碍和功能损害进行标准化评估可能会改善对需要紧急移植的患者的识别,从而降低延迟移植可能发生的发病率和死亡率。